Lv62
2760 积分 2021-01-06 加入
Efficacy and safety of empagliflozin in combination with insulin in Chinese patients with type 2 diabetes and insufficient glycaemic control: A phase III, randomized, double‐blind, placebo‐controlled, parallel study
3小时前
已完结
Calculating qualified non-mutagenic impurity levels: Harmonization of approaches
7天前
已完结
Comparison of Hetrombopag and Eltrombopag Added to First‐Line Immunosuppressive Therapy in Severe Aplastic Anemia
2个月前
已完结
皖公网安备34019202002308
